POET Technologies Inc (POET)
🔔 Watch stock
symbol.quality_heading
The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.
Yellow here marks an open operating question, not a substance risk: the balance sheet is sound — $429.1 million of liquid assets against $13.1 million of liabilities (March 31, 2026), no need for credit lines, no going-concern paragraph left in the statements, and the 2024 control weakness remediated and attested. What is missing is proof that anyone buys this technology in volume: $1.07 million of annual revenue, mostly one-off engineering work, and the only production order in company history was cancelled in April 2026. That the stock trades at roughly 1,085 times annual revenue (market value $1.17 billion, data as of July 28, 2026) is a price argument and does not move the light — it only changes how little room for disappointment remains. This turns green once two or three consecutive quarters show announcements becoming shipments. The decision is yours.
symbol.quality_note
POET Technologies builds optical chips for AI data centers, and the technology story is a good one: the Optical Interposer is meant to take costly hand assembly out of transceiver manufacturing. The filings with the U.S. securities regulator, the SEC, tell the second half. In 2025, $1,074,865 of revenue faced $43.17 million of operating expenses; shares outstanding grew from 76.5 million to 172.6 million; and in April 2026 Marvell cancelled every order from the first production contract in company history — stating that POET had breached confidentiality. We do the arithmetic on how much of this valuation rests on contracts and how much on anticipation.
Read the analysis
Stock Watch
This analysis is as of July 29, 2026. Stock Watch will tell you what's changed at POET since then.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 4 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 7.00 $ — 17% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
Sells AIPOETs verkaufte Produkte — optische Engines für 800G/1,6T-Transceiver und die Blazar-Lichtquellen — richten sich laut Jahresbericht 20-F für 2025 und den Zwischenmitteilungen 6-K ausdrücklich an den Markt für Künstliche Intelligenz und an Hyperscale-Rechenzentren, die KI-Dienste betreiben; der 2025 erlöste Umsatz von 1.074.865 US-Dollar stammt aus genau diesen Produkten und den zugehörigen Entwicklungsleistungen.
View the full file — quotes, sources, reviewed filings
„Our sales of these products will be to module makers that are heavily focused on selling to hyperscale data centers actively implementing AI services."
Unsere Verkäufe dieser Produkte werden an Modulhersteller gehen, die stark darauf ausgerichtet sind, an Hyperscale-Rechenzentren zu verkaufen, die aktiv KI-Dienste einführen.
„In 2025, we focused primarily on developing Optical Engines operating at 800Gps, and heavily focused on those hyperscale data centers actively implementing AI services."
2025 haben wir uns vor allem auf die Entwicklung optischer Engines mit 800 Gbit/s konzentriert und dabei stark auf jene Hyperscale-Rechenzentren, die aktiv KI-Dienste einführen.
„The rapid growth of AI software systems, including large language models and agents, represents a profound opportunity for POET."
Das rasche Wachstum von KI-Softwaresystemen, einschließlich großer Sprachmodelle und Agenten, stellt eine tiefgreifende Chance für POET dar.
„POET is a design and development company offering high-speed optical engines, light source products and custom optical modules to the artificial intelligence systems market and to hyperscale data centers."
POET ist ein Entwicklungsunternehmen, das schnelle optische Engines, Lichtquellen-Produkte und kundenspezifische optische Module für den Markt der Systeme Künstlicher Intelligenz und für Hyperscale-Rechenzentren anbietet.
Filings Reviewed: 20-F 2026-03-31 · 6-K 2026-05-15 · 6-K 2026-06-30 · 6-K 2026-04-27 · 6-K 2026-04-15 · 424B5 2026-05-18
Rated on July 29, 2026 · How the Rating Is Built
Analysts & Price Target
The price target sits 150.0% above the current price.
- Consensus
- Strong Sell
- Analyst Ratings
- 2
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.24 | -0.24 – -0.24 | 14 | 40.3% | 1 |
| 12/31/2027 | -0.17 | -0.17 – -0.17 | 138 | 29.2% | 1 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- -0.08 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q2 | -0.12 | -9.10 | 0 | -100.00 | – | -5 | -6 |
| 2024: Q3 | -0.03 | 76.90 | 0 | -97.90 | -345,740.50 | -6 | -7 |
| 2024: Q4 | -0.17 | -33.80 | 0 | -73.00 | -104,227.20 | -9 | -13 |
| 2025: Q1 | -0.12 | 0.00 | 0 | 1,823.20 | 3,802.80 | -9 | -10 |
| 2025: Q2 | -0.10 | 16.70 | 0 | – | -6,430.30 | -8 | -10 |
| 2025: Q3 | -0.10 | -233.30 | 0 | 7,998.60 | -3,139.60 | -3 | -3 |
| 2025: Q4 | -0.25 | -43.80 | 0 | 1,075.30 | -12,506.30 | -12 | -12 |
| 2026: Q1 | -0.32 | -169.30 | 1 | 201.90 | -2,452.20 | -9 | -11 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 2 | -14 | -13 | -0.60 | -10 | 32 | 36 |
| 2017 | 3 | -13 | -13 | -0.49 | -9 | 23 | 25 |
| 2018 | 4 | -17 | -16 | -0.58 | -9 | 21 | 25 |
| 2019 | 4 | -9 | -11 | -0.40 | -9 | 19 | 24 |
| 2020 | 4 | -18 | -19 | -0.66 | -9 | 6 | 12 |
| 2021 | 0 | -16 | -16 | -0.45 | -11 | 25 | 27 |
| 2022 | 1 | -20 | -21 | -0.57 | -12 | 11 | 15 |
| 2023 | 0 | -20 | -20 | -0.51 | -15 | 5 | 9 |
| 2024 | 0 | -30 | -57 | -0.94 | -23 | 21 | 70 |
| 2025 | 1 | -34 | -63 | -0.68 | -31 | 184 | 329 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Assessment: Opportunities & Risks
As of March 31, 2026 the company held $429.1 million of liquid assets ($16.5 million of cash plus $412.6 million of guaranteed investment certificates) against $13.1 million of total liabilities; $400 million gross was added on May 18, 2026. At roughly $9 million of quarterly operating cash burn, funding is secured for years without any bank debt.
2025 revenue of $1,074,865 against $43.17 million of operating expenses — arithmetically nine days of operating costs. It comes mostly from one-off engineering services. Volume production is only meant to begin in the second half of 2026; the annual report concedes the product "may never gain widespread acceptance by large data center operators".
Marvell Semiconductor cancelled every order from the first production contract, announced in 2023, on April 23, 2026 — alleging that POET had breached its confidentiality obligations. The annual report itself states that customers are not committed beyond firm purchase orders. The Lumilens order of $50 million (May 14, 2026) is so far an announcement, not booked revenue.
From 76,507,157 shares (January 1, 2025) to 172,590,000 (June 26, 2026), and 238.1 million fully exercised — up to 261.0 million counting the warrant on 22,921,408 shares that POET granted its customer Lumilens on May 14, 2026. Net tangible book value was $2.94 per share as of March 31, 2026 and $4.92 after the offering, against a $21.00 offering price in May — the prospectus itself puts the immediate dilution to the new investor at $16.08 per share.
The material weakness identified for 2024 is deemed remediated as of December 31, 2025, the auditors issued an unqualified opinion and were confirmed with 97 percent of votes on June 26, 2026. Three items remain open: the PFIC status for 2025 with the resolved U.S. redomiciliation (for 2026 POET expects no PFIC status), $30 million lent to a borrower the filings never name, and a legal action pending after March 31, 2026 that the interim statements merely mention and assess as not material, without naming party or subject.
POET Technologies is the blueprint trap in its purest form: a plausible, patented technology for a genuinely growing market — and next to it an income statement in which $1,074,865 of 2025 revenue meets $43.17 million of operating expenses. The balance sheet is exceptional, with $429.1 million of liquid assets (March 31, 2026) plus $400 million from the May offering, and it was paid for by doubling the share count to 172.6 million. The most important order in company history was cancelled in April 2026 because the customer accuses POET of breaching confidentiality; for 2025 U.S. tax law treats the company as a passive investment vehicle. Anyone buying in buys time and an expectation — both available in abundance, just not yet sold. Not investment advice.
- This analysis did not start from a scanner hit — POET appeared in none of our scanner lists as of July 29, 2026 — but from the SEC filing stream: the cancellation of all Marvell purchase orders on April 27, 2026 and the $400 million offering of May 15/18, 2026.
- Data basis: annual figures from the 20-F for 2025 (December 31, 2025), interim figures from the statements as of March 31, 2026, share count from the 6-K of June 30, 2026. Fundamental data as of July 29, 2026.
- The market value from fundamental data ($1,166,708,480) was checked against the filings and passed: the share count it carries, 172,590,000, is exactly what POET reported for its annual meeting of 06/26/2026, and 172,595,406 shares from the prospectus supplement × $6.76 closing price of 07/28/2026 gives $1,166,744,945 — a deviation of 0.003 percent. The article therefore uses it as a dated anchor (as of 07/28/2026).
- The older filing prices ($8.37 on 01/21/2026, $5.93 on 03/20/2026, $20.57 on 05/14/2026, $15.97 on 05/15/2026) are historical anchors and expressly not today's valuation. The stock has fallen well below the May offering price of $21.00; that gap is named in the dilution chapter as a documented finding, not as a forecast.
- Easy to confuse: POET Technologies is a Canadian corporation reporting as a foreign private issuer (20-F, 6-K). No U.S. quarterly report (10-Q) exists; anyone searching for one finds nothing and wrongly concludes the company is opaque. Its former SEC name is OPEL International Inc. Second trap: older press releases still carry "TSX Venture: PTK" in the header — per the 20-F for 2025 the Canadian listing already ended in 2024, and the shares trade only on Nasdaq.
- Second pitfall, on net tangible book value: the $2.94 per share in the prospectus supplement of 05/18/2026 is expressly the "historical" figure as of 03/31/2026 — before the $400 million offering and calculated on 152.9 million shares. The same table gives $4.92 per share for the period after it. Comparing the 07/28/2026 price against the $2.94 would make the stock look dearer relative to its substance than it is; the article therefore works with $4.92 (roughly 1.4 times).
- Dilution pitfall in this analysis: the prospectus supplement of 05/18/2026 lists options, warrants and share units with a weighted-average warrant exercise price of $4.39 — exactly the 03/31/2026 position. The warrant on up to 22,921,408 shares at $8.25 that POET granted its customer Lumilens on 05/14/2026 is not included there. The fully diluted share count is therefore up to 261.0 million, not 238.1 million.
- The whole price chain — $8.37 (January 21, 2026), $5.93 (March 20, 2026), $20.57 (May 14, 2026), $15.97 (May 15, 2026), $6.76 (July 28, 2026) — is dated and documented; it appears in the article as evidence of how the price forms, not as a price forecast.
About the Company
POET Technologies Inc., together with its subsidiaries, designs, develops, manufactures, and sells semiconductor products and services for commercial applications in the United States, Canada, the rest of North and South America, Europe, Malaysia, Singapore, China, and the rest of Asia. The company offers photonic integrated packaging solutions based on the POET Optical Interposer, a platform that allows the integration of electronic and photonic devices onto a single chip using advanced wafer-level semiconductor manufacturing techniques. Its products include photonic integrated circuits, optical engines, optical transceiver modules, and light source products. The company serves the data center AI, light source, and telecommunications markets; 5G interconnect markets, such as PON and GPON, as well as edge computing for machine-to-machine communications; and sensing markets, including LIDAR, Optical Coherence Tomography for medical devices, and virtual reality systems. The company has a strategic collaboration with Lumilens Inc. for the development of wafer-level photonic integration for AI optical networks. The company was formerly known as Opel Technologies Inc. and changed its name to POET Technologies Inc. in June 2013. POET Technologies Inc. is headquartered in Toronto, Canada.
| Employees | 80 |
|---|---|
| Headquarters | Toronto, ON |
| Address | 120 Eglinton Avenue East, M4P 1E2 Toronto, Canada |
| Phone | 416 368 9411 |
| Website | poet-technologies.com |
| IPO Date | 4. Jan 2016 |
| ISIN | CA73044W3021 |
| Stock Split | 1:10 on 02/28/2022 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Suresh V. Venkatesan Ph.D. | Executive Chairman & CEO | 1967 |
| Thomas R. Mika MBA | Executive VP, CFO & Corporate Secretary | 1953 |
| Yong Meng Lee | Senior Vice President of Interposer Development & Engineering | 1972 |
| Jinyu Mo | Senior Vice President of Global Product Development | 1975 |
| Raju Kankipati | Chief Revenue Officer | 1978 |
| Robert Ditizio | Vice President of Intellectual Property | 1963 |
| Sandeep P. Kumar Ph.D. | Chief Operating Officer | 1965 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.